In a statement released yesterday, Bristol-Myers Squibb chairman and CEO Giovanni Caforio has been named chairman of the Pharmaceutical Research and Manufacturers of America (PhRMA) board of directors. He succeeds Oliver Brandicourt, who recently retired from his position as Sanofi’s CEO.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,